<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"><url><loc>https://medichelpline.com/clinical-feed/who-1-26-countries-progress-negotiations-in-support-of-who-pandemic-agreement</loc><lastmod>2026-04-07T01:00:03.794Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/european-urology-42-reply-to-the-harry-herr-s-letter-to-the-editor-re-oscar-buisan-pol-servian-sonia-pedre-o-lopez-et-al-a-novel-heterologous-prime-boost-strategy-using-ruti-vaccine-to-improve-the-bacillus-calmette-gu-rin-response-in-non-muscle-invasive-bladder-cancer-patients-phase-1-rutivac-1-trial-eur-urol-in-press-https-doi-org-10-1016-j-eururo-2025-08-014</loc><lastmod>2026-04-04T09:52:09.903Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-hepatology-77-revisiting-prophylactic-corticosteroids-to-mitigate-severe-immune-related-adverse-events-in-hepatocellular-carcinoma</loc><lastmod>2026-04-04T09:39:59.586Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/kidney-international-72-targeting-cellular-senescence-in-diabetic-kidney-disease-potential-of-regenerative-cell-based-therapies-and-other-senotherapeutic-approaches</loc><lastmod>2026-04-04T09:57:43.928Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/clinicaltrials-nct07361679</loc><lastmod>2026-04-07T04:38:15.270Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-23-neoadjuvant-taxane-plus-trastuzumab-and-pertuzumab-with-or-without-carboplatin-in-human-epidermal-growth-factor-receptor-2-positive-breast-cancer-the-randomized-noninferiority-phase-iii-neocarhp-trial</loc><lastmod>2026-04-06T21:11:41.842Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/the-lancet-respiratory-medicine-10-considering-molecular-pharmacology-for-sarcoidosis-treatment</loc><lastmod>2026-04-06T20:57:59.481Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/litfl-10-auto-appendicectomy</loc><lastmod>2026-04-07T07:26:38.660Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/endocrine-news-38-people-with-obesity-may-have-a-higher-risk-of-dementia</loc><lastmod>2026-04-06T12:11:54.701Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/cancer-cell-8-tumor-antigen-independent-targeting-of-solid-tumors-by-armored-macrophage-directed-anti-trem2-car-t-cells</loc><lastmod>2026-04-06T15:47:01.427Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/cancer-cell-9-armored-macrophage-targeted-car-t-cells-reset-and-reprogram-the-tumor-microenvironment-and-control-metastatic-cancer-growth</loc><lastmod>2026-04-06T15:47:03.289Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/cancer-cell-15-igsf11-vista-is-a-critical-and-targetable-immune-checkpoint-axis-in-diffuse-midline-glioma</loc><lastmod>2026-04-06T15:47:05.189Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/european-urology-43-reconstruction-of-a-devastated-ureter-multi-institutional-experience-with-robotic-intracorporeal-ileal-ureter-replacement</loc><lastmod>2026-04-04T09:52:16.014Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-hepatology-78-yttrium-90-radioembolization-is-associated-with-a-lower-risk-of-liver-transplant-waitlist-dropout-than-chemoembolization-in-hepatocellular-carcinoma</loc><lastmod>2026-04-04T09:40:01.394Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-hepatology-79-a-single-cell-atlas-of-the-woodchuck-liver-reveals-cellular-programs-conserved-in-human-hbv-infection</loc><lastmod>2026-04-04T09:40:02.957Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-hepatology-80-incidence-and-implications-of-abstinence-induced-recompensation-in-alcohol-related-cirrhosis</loc><lastmod>2026-04-04T09:40:04.795Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-hepatology-81-updated-data-from-imbrave050-adjuvant-atezolizumab-plus-bevacizumab-for-high-risk-hepatocellular-carcinoma</loc><lastmod>2026-04-04T09:40:06.542Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/kidney-international-73-primary-hyperoxaluria-s-from-trials-to-real-life-data-and-pipeline-therapies</loc><lastmod>2026-04-04T09:57:46.128Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/kidney-international-74-heat-shock-protein-70s-are-modifiers-of-endothelial-function-in-fabry-disease</loc><lastmod>2026-04-04T09:57:48.501Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/clinicaltrials-nct07359586</loc><lastmod>2026-04-07T04:38:16.926Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/clinicaltrials-nct07358741</loc><lastmod>2026-04-07T04:38:18.489Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-15-bridging-the-gap-advancing-first-line-therapy-for-patients-with-metastatic-human-epidermal-growth-factor-receptor-2-positive-breast-cancer</loc><lastmod>2026-04-06T21:11:45.192Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-81-delta-like-ligand-3-expression-across-lung-neuroendocrine-subtypes-interpreting-response-in-small-cell-lung-cancer-and-beyond</loc><lastmod>2026-04-04T09:57:11.203Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-96-reply-to-delta-like-ligand-3-expression-across-lung-neuroendocrine-subtypes-interpreting-response-in-small-cell-lung-cancer-and-beyond</loc><lastmod>2026-04-04T09:56:36.518Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/who-1-27-who-renews-commitment-to-a-leprosy-free-world-spotlighting-partnership-and-progress-ahead-of-world-leprosy-day</loc><lastmod>2026-04-07T01:00:05.480Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/who-1-28-new-guide-promotes-safe-inclusive-and-child-friendly-public-spaces</loc><lastmod>2026-04-07T01:04:56.189Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/european-urology-44-active-surveillance-versus-intravesical-bacillus-calmette-gu-rin-for-high-grade-t1-bladder-cancer-with-negative-second-transurethral-resection-the-randomized-noninferiority-phase-3-jcog1019-trial</loc><lastmod>2026-04-04T09:52:18.501Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-hepatology-82-af6-knockout-induced-upregulation-of-bile-acid-production-promotes-cxcl14-mediated-antitumor-immunity-in-hcc</loc><lastmod>2026-04-04T09:40:08.879Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/kidney-international-75-eligibility-timing-and-organ-quality-indications-and-outcomes-of-kidney-transplantation-in-older-patients</loc><lastmod>2026-04-04T09:57:50.695Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/kidney-international-76-a-predictor-finding-study-found-patient-reported-outcomes-improve-the-prediction-of-mortality-of-incident-dialysis-patients</loc><lastmod>2026-04-04T09:57:54.021Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/clinicaltrials-nct05423301</loc><lastmod>2026-04-07T12:16:41.905Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/clinicaltrials-nct07002476</loc><lastmod>2026-04-09T02:14:38.512Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-21-randomized-phase-ii-iii-trial-comparing-hepatectomy-followed-by-mfolfox6-with-hepatectomy-alone-for-liver-metastasis-from-colorectal-cancer-long-term-results-of-jcog0603</loc><lastmod>2026-04-06T21:11:47.789Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-57-is-unmutated-igg1-a-wrong-choice-for-therapeutic-antibodies-targeting-immune-checkpoints-lessons-from-the-clinical-failures-of-the-first-anti-tigit-antibodies</loc><lastmod>2026-04-04T09:56:42.271Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-58-is-it-time-to-move-beyond-graft-versus-host-disease-free-relapse-free-survival-as-a-primary-end-point-in-clinical-trials-for-hematopoietic-cell-transplantation-</loc><lastmod>2026-04-04T09:56:45.034Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/european-urology-45-targeting-prostatic-acid-phosphatase-in-prostate-cancer-roadmap-on-how-to-venture-above-and-beyond-prostate-specific-membrane-antigen-with-acp3-theranostics</loc><lastmod>2026-04-04T09:52:21.944Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-thoracic-oncology-33-hiding-in-plain-sight-the-neuro-protective-benefit-of-tropomyosin-receptor-kinase-inhibition-in-non-neurotrophic-receptor-tyrosine-kinase-driven-lung-cancers</loc><lastmod>2026-04-06T14:22:40.546Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/kidney-international-77-taking-the-unknown-out-of-ckdu-optimizing-approaches-to-uncover-the-cause-s-of-epidemic-level-kidney-disease-in-low-and-middle-income-settings-a-report-from-the-isn-s-international-consortium-of-ckdu-collaborators-isn-i3c-</loc><lastmod>2026-04-04T09:57:56.581Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/kidney-international-78-multi-omics-analyses-reveal-the-pathogenic-role-of-terminal-ileum-derived-iga-7-cells-in-iga-nephropathy</loc><lastmod>2026-04-04T09:57:59.378Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/kidney-international-79-uremia-and-parathyroid-hormone-have-distinct-effects-on-bone-protein-and-gene-expression</loc><lastmod>2026-04-04T09:58:01.388Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/kidney-international-80-a-secondary-analysis-of-the-testing-trial-predicted-individual-patient-response-to-corticosteroid-treatment-in-iga-nephropathy</loc><lastmod>2026-04-04T09:57:41.461Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/annals-of-internal-medicine-3-effect-of-social-vulnerability-on-efficacy-of-bariatric-surgery-versus-medical-and-lifestyle-intervention-for-type-2-diabetes-analysis-of-the-armms-t2d-consortium-of-randomized-trials</loc><lastmod>2026-04-07T07:49:16.269Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/annals-of-internal-medicine-4-long-term-mpox-sequelae-11-to-18-months-after-acute-illness</loc><lastmod>2026-04-07T07:49:17.755Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/annals-of-internal-medicine-11-grade-guidance-update-on-developing-good-practice-statements-in-guidelines</loc><lastmod>2026-04-07T07:49:19.745Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/annals-of-internal-medicine-18-actionable-and-evidence-based-practice-statements-can-we-do-better-</loc><lastmod>2026-04-07T07:49:21.475Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/annals-of-internal-medicine-21-misconceptions-about-whether-seeking-mental-health-care-jeopardizes-lawful-firearm-ownership-a-national-survey</loc><lastmod>2026-04-07T07:49:22.991Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/annals-of-internal-medicine-28-be-better-at-benzos</loc><lastmod>2026-04-07T07:52:25.191Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/annals-of-internal-medicine-48-summary-for-patients-long-term-mpox-sequelae-11-to-18-months-after-acute-illness</loc><lastmod>2026-04-06T07:23:05.383Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-73-limitations-in-study-design-and-stratification-in-phase-ii-stereotactic-radiosurgery-trial-for-small-cell-lung-cancer-brain-metastases</loc><lastmod>2026-04-04T09:56:47.441Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-74-radiosurgery-for-small-cell-lung-cancer-brain-metastases-comparing-the-jlgk0901-and-bwh-dfci-trials</loc><lastmod>2026-04-04T09:56:49.648Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-79-from-thresholds-to-tumor-sidedness-reframing-human-epidermal-growth-factor-receptor-2-in-colorectal-cancer</loc><lastmod>2026-04-04T09:56:51.951Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-80-expanding-indications-for-stereotactic-radiosurgery-in-small-cell-lung-cancer-with-brain-metastases</loc><lastmod>2026-04-04T09:56:54.073Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-94-reply-to-from-thresholds-to-tumor-sidedness-reframing-human-epidermal-growth-factor-receptor-2-in-colorectal-cancer</loc><lastmod>2026-04-04T09:56:56.353Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-95-reply-to-limitations-in-study-design-and-stratification-in-phase-ii-stereotactic-radiosurgery-trial-for-small-cell-lung-cancer-brain-metastases-radiosurgery-for-small-cell-lung-cancer-brain-metastases-comparing-the-jlgk0901-and-bwh-dfci-trials-and-expanding-indications-for-stereotactic-radiosurgery-in-small-cell-lung-cancer-with-brain-metastases-</loc><lastmod>2026-04-04T09:56:58.711Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/european-urology-46-regional-node-positive-bladder-cancer-therapeutic-decisions-based-on-trial-results-in-perioperative-and-advanced-disease-settings</loc><lastmod>2026-04-04T09:52:23.229Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/european-urology-47-re-maria-de-santis-joan-palou-redorta-hiroyuki-nishiyama-et-al-durvalumab-in-combination-with-bcg-for-bcg-naive-high-risk-non-muscle-invasive-bladder-cancer-potomac-final-analysis-of-a-randomised-open-label-phase-3-trial-lancet-2025-406-2221-34</loc><lastmod>2026-04-04T09:52:25.428Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-thoracic-oncology-34-biology-and-clinical-management-of-non-v600-braf-alterations-in-nsclc</loc><lastmod>2026-04-06T14:22:42.351Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/kidney-international-81-sodium-glucose-transporter-2-inhibition-maintains-kidney-antibacterial-response-by-decreasing-complement-c1q</loc><lastmod>2026-04-04T09:57:43.847Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/kidney-international-82-parasympathetic-nerves-in-the-kidney-pelvis-contribute-to-blood-pressure-regulation</loc><lastmod>2026-04-04T09:57:45.757Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/kidney-international-83-genotype-phenotype-characteristics-and-disease-progression-of-fan1-related-karyomegalic-tubulointerstitial-nephropathy</loc><lastmod>2026-04-04T09:57:48.501Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/european-urology-48-bladder-preservation-therapy-in-combination-with-atezolizumab-and-radiation-therapy-bpt-art-for-invasive-bladder-cancer-final-analysis-from-a-multicentre-open-label-prospective-phase-2-trial</loc><lastmod>2026-04-04T09:52:26.858Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-hepatology-84-is-liver-steatosis-a-disease-or-the-emperor-s-new-clothes-</loc><lastmod>2026-04-04T09:40:15.697Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/who-1-29-message-for-world-leprosy-day-2026</loc><lastmod>2026-04-07T01:05:00.550Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/who-1-30-who-egypt-launches-a-new-national-training-of-trainers-programme-on-mass-casualty-management</loc><lastmod>2026-04-07T01:05:02.283Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/european-urology-49-refining-salvage-radiotherapy-after-prostatectomy-positron-emission-tomography-guided-dose-escalation-in-empire-2</loc><lastmod>2026-04-04T09:52:09.401Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-thoracic-oncology-35-loss-of-payload-sensitivity-and-other-mechanisms-of-resistance-to-t-dxd-in-her2-mutant-nsclc-implications-for-subsequent-responsiveness-to-her2-tkis</loc><lastmod>2026-04-06T14:27:38.502Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-hepatology-85-thrombotic-microangiopathy-or-rejection-in-first-pig-to-human-patient-liver-xenotransplantation</loc><lastmod>2026-04-04T09:40:18.231Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-hepatology-86-is-partial-cure-a-realistic-endpoint-for-novel-hepatitis-b-therapy-</loc><lastmod>2026-04-04T09:40:20.336Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-55-when-the-system-is-the-treatment-rethinking-nonpharmacologic-breakthroughs-in-oncology</loc><lastmod>2026-04-04T09:56:37.996Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-56-ending-the-controversy-around-pretreatment-dihydropyrimidine-dehydrogenase-dpd-dpyd-testing-heightens-the-controversy-over-appropriate-fluoropyrimidine-dosing</loc><lastmod>2026-04-04T09:56:41.695Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-72-blood-brain-barrier-heterogeneity-in-nrg-bn007-implications-for-immunotherapy-delivery</loc><lastmod>2026-04-04T09:56:44.283Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-93-reply-to-blood-brain-barrier-heterogeneity-in-nrg-bn007-implications-for-immunotherapy-delivery</loc><lastmod>2026-04-04T09:56:46.381Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/the-lancet-respiratory-medicine-15-eugenio-morelli-a-pioneer-of-pneumotherapy-and-his-portable-apparatus-for-artificial-pneumothorax</loc><lastmod>2026-04-06T20:58:01.609Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/litfl-11-fernand-cathelin</loc><lastmod>2026-04-07T07:26:40.170Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/cancer-cell-11-axes-of-biological-variation-in-diffuse-large-b-cell-lymphoma</loc><lastmod>2026-04-06T15:47:06.996Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/cancer-cell-17-a-context-augmented-large-language-model-for-accurate-precision-oncology-medicine-recommendations</loc><lastmod>2026-04-06T16:18:36.333Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/who-1-31-updated-who-manuals-provide-guidance-to-strengthen-foodborne-disease-surveillance-and-response-capacities-worldwide</loc><lastmod>2026-04-07T01:05:03.780Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/european-urology-50-the-hype-and-the-hope-where-do-we-stand-with-prostate-specific-membrane-antigen-targeted-fluorescence-guided-surgery-</loc><lastmod>2026-04-04T09:52:12.414Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/european-urology-51-re-primary-retroperitoneal-lymph-node-dissection-in-marker-positive-clinical-stage-ii-non-seminomatous-germ-cell-tumours</loc><lastmod>2026-04-04T09:52:15.358Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/european-urology-52-the-discovery-of-prostate-specific-membrane-antigen-ligands-the-long-road-to-changes-in-clinical-practice-for-prostate-cancer</loc><lastmod>2026-04-04T09:52:17.746Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/european-urology-53-re-a-multicenter-randomized-phase-ii-trial-of-lenvatinib-plus-everolimus-versus-cabozantinib-in-patients-with-metastatic-clear-cell-rcc-that-progressed-on-pd-1-immune-checkpoint-inhibition-lencabo-</loc><lastmod>2026-04-04T09:52:19.854Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-70-reply-to-mifamurtide-in-nonmetastatic-high-grade-osteosarcoma</loc><lastmod>2026-04-04T09:56:48.782Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-71-mifamurtide-in-nonmetastatic-high-grade-osteosarcoma</loc><lastmod>2026-04-04T09:56:50.798Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/endocrine-news-39-new-research-connections-how-dknet-allows-access-to-the-research-information-superhighway</loc><lastmod>2026-04-06T12:11:56.482Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/who-1-33-cheaper-drinks-will-see-a-rise-in-noncommunicable-diseases-and-injuries</loc><lastmod>2026-04-07T01:39:34.808Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/european-urology-54-re-disitamab-vedotin-plus-toripalimab-in-her2-expressing-advanced-urothelial-cancer</loc><lastmod>2026-04-04T09:52:22.095Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/european-urology-55-re-open-versus-robotic-assisted-partial-nephrectomy-in-patients-with-intermediate-high-complexity-kidney-tumours-final-results-of-the-randomised-controlled-open-label-multicentre-trial-opera</loc><lastmod>2026-04-04T09:52:23.541Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-hepatology-87-single-nucleotide-polymorphisms-in-the-bepirovirsen-binding-site-have-limited-impact-on-treatment-response-in-chronic-hepatitis-b</loc><lastmod>2026-04-04T09:41:01.727Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-hepatology-88-reply-to-reassessing-the-l-reuteri-indole-3-lactic-acid-pathway-in-tace-related-liver-injury-</loc><lastmod>2026-04-04T09:41:04.006Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-1-quiet-work-of-clarity</loc><lastmod>2026-04-09T00:12:09.398Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/annals-of-internal-medicine-0-predicting-long-term-risk-for-prostate-cancer-mortality-following-a-prostate-specific-antigen-screening-test-prognostic-model-development-and-external-validation</loc><lastmod>2026-04-08T23:57:55.569Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/annals-of-internal-medicine-6-the-prevalence-and-characteristics-of-difficult-patient-encounters</loc><lastmod>2026-04-07T07:52:28.429Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/annals-of-internal-medicine-16--difficult-patients-persistent-symptoms-and-the-biopsychosocial-model</loc><lastmod>2026-04-07T07:52:30.493Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/annals-of-internal-medicine-25-correction-comparison-of-an-energy-reduced-mediterranean-diet-and-physical-activity-versus-an-ad-libitum-mediterranean-diet-in-the-prevention-of-type-2-diabetes</loc><lastmod>2026-04-07T07:52:33.145Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/annals-of-internal-medicine-29-q-a-looking-beyond-the-cdc</loc><lastmod>2026-04-07T08:52:44.873Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/annals-of-internal-medicine-46-annals-video-summary-the-prevalence-and-characteristics-of-difficult-patient-encounters-a-systematic-review-and-meta-analysis</loc><lastmod>2026-04-06T07:23:19.419Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/endocrine-news-40-covid-19-infection-linked-to-relapse-of-rare-endocrine-disorder-after-19-years</loc><lastmod>2026-04-04T09:44:44.107Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/clinicaltrials-nct07334028</loc><lastmod>2026-04-03T12:56:28.473Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/european-urology-56-re-ctdna-guided-adjuvant-atezolizumab-in-muscle-invasive-bladder-cancer</loc><lastmod>2026-04-04T09:52:25.502Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/european-urology-57-re-oscar-buisan-pol-servian-sonia-pedre-o-lopez-et-al-a-novel-heterologous-prime-boost-strategy-using-ruti-vaccine-to-improve-the-bacillus-calmette-gu-rin-response-in-non-muscle-invasive-bladder-cancer-patients-phase-1-rutivac-1-trial-eur-urol-in-press-https-doi-org-10-1016-j-eururo-2025-08-014</loc><lastmod>2026-04-04T09:52:27.256Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-thoracic-oncology-36-changes-in-cardiac-function-in-patients-receiving-radiation-therapy-for-lung-cancer</loc><lastmod>2026-04-06T14:27:40.312Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-thoracic-oncology-37-osimertinib-and-stereotactic-radiosurgery-for-brain-metastases-in-egfr-mutated-lung-cancer-the-starlet-joint-analysis-of-outrun-and-luosicns-randomized-trials</loc><lastmod>2026-04-06T14:27:42.263Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/clinicaltrials-nct03720860</loc><lastmod>2026-04-07T04:41:41.524Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-10-focal-boosting-in-localized-prostate-cancer-in-the-era-of-systemic-therapy-and-prostate-specific-membrane-antigen-imaging</loc><lastmod>2026-04-06T21:57:06.632Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-11-reply-to-focal-boosting-in-localized-prostate-cancer-in-the-era-of-systemic-therapy-and-prostate-specific-membrane-antigen-imaging</loc><lastmod>2026-04-06T21:57:08.558Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-hepatology-89-in-memoriam-professor-stephanos-j-hadziyannis</loc><lastmod>2026-04-04T09:41:05.506Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/endocrine-news-41-remembering-joel-habener-md</loc><lastmod>2026-04-04T09:44:45.830Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/endocrine-news-42-pharma-friday-january-9-2026</loc><lastmod>2026-04-04T09:44:47.465Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/endocrine-news-43-meet-the-2026-laureates</loc><lastmod>2026-04-04T09:44:35.130Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/who-1-34-sudan-1000-days-of-war-deepen-the-world-s-worst-health-and-humanitarian-crisis</loc><lastmod>2026-04-07T01:39:36.266Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/european-urology-58-re-acox2-destabilizes-the-mre11-rad50-nbs1-complex-and-boosts-anticancer-immunity-via-the-cgas-sting-pathway-in-clear-cell-renal-cell-carcinoma</loc><lastmod>2026-04-04T09:52:28.885Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-hepatology-90-bridging-disciplines-in-portopulmonary-hypertension-a-multidisciplinary-call-for-harmonized-patient-management</loc><lastmod>2026-04-04T09:41:07.958Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-hepatology-91-emergency-granulopoiesis-in-decompensated-cirrhosis-mechanistic-and-therapeutic-considerations</loc><lastmod>2026-04-04T09:40:07.314Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-hepatology-92-hypertension-and-long-term-adverse-clinical-outcomes-in-masld-sensitivity-analyses-for-unmeasured-or-uncontrolled-confounding</loc><lastmod>2026-04-04T09:40:09.012Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-hepatology-93-reply-to-masld-fibrosis-stage-f3-is-morphologically-and-transcriptomically-diverse-implications-for-assessing-therapeutic-response-</loc><lastmod>2026-04-04T09:40:11.109Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/clinicaltrials-nct05835154</loc><lastmod>2026-04-07T04:41:43.045Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/endocrine-news-44-new-directions-in-thyroid-care-minimizing-risk-maximizing-choice</loc><lastmod>2026-04-04T09:44:36.893Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/endocrine-news-45-endocrine-experts-advise-on-hormone-therapy-safety-for-menopause-stress-holistic-care</loc><lastmod>2026-04-04T09:44:38.733Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/cancer-cell-0-the-adapt-learning-cancer-treatment-system-arpa-h-s-initiative-to-revolutionize-cancer-therapy</loc><lastmod>2026-04-08T21:29:05.237Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/cancer-cell-1-framework-for-cancer-evolution-profiling-and-interception-in-colorectal-cancer-ascend-crc-program</loc><lastmod>2026-04-08T21:29:07.164Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/cancer-cell-10-b-cells-disrupt-tertiary-lymphoid-structure-formation-and-suppress-anti-tumor-immunity</loc><lastmod>2026-04-06T16:18:41.648Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/nlm-news-2-nlm-colloquia-harnessing-ai-and-informatics-for-dementia-and-aging-research</loc><lastmod>2026-04-06T22:03:39.336Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/nlm-general-announcements-3-nlm-colloquia-harnessing-ai-and-informatics-for-dementia-and-aging-research</loc><lastmod>2026-04-06T10:34:59.907Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/endocrine-news-46-newell-price-named-clinical-research-director-at-sheffield-teaching-hospitals-nhs-foundation-trust</loc><lastmod>2026-04-04T09:44:40.686Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/who-1-35-who-releases-updated-recommendations-on-hiv-clinical-management</loc><lastmod>2026-04-07T01:39:37.691Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/clinicaltrials-nct05642715</loc><lastmod>2026-04-08T13:29:57.699Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-9-gene-therapy-related-malignancy-and-the-risk-of-cancer-exceptionalism</loc><lastmod>2026-04-06T21:57:10.332Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/endocrine-news-47-remembering-the-grandfather-of-molecular-endocrinology-bert-w-o-malley-md</loc><lastmod>2026-04-04T09:44:42.941Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/who-1-36-global-population-requiring-interventions-against-trachoma-falls-below-100-million-for-the-first-time</loc><lastmod>2026-04-07T01:39:39.115Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/annals-of-internal-medicine-2-effectiveness-of-sodium-glucose-cotransporter-2-inhibitors-versus-glucagon-like-peptide-1-receptor-agonists-on-diabetic-foot-disease</loc><lastmod>2026-04-07T08:52:46.679Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-clinical-oncology-7-treatment-of-multiple-myeloma-asco-ontario-health-cancer-care-ontario-living-guideline</loc><lastmod>2026-04-06T21:57:12.216Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/endocrine-news-48-highly-recommended-writing-recommendation-letters</loc><lastmod>2026-04-04T09:44:44.464Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/endocrine-news-49-find-new-ways-to-contribute-to-the-society-this-year</loc><lastmod>2026-04-04T09:44:46.319Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url><url><loc>https://medichelpline.com/clinical-feed/journal-of-thoracic-oncology-38-journal-of-thoracic-oncology-20th-anniversary-series-surgery</loc><lastmod>2026-04-06T14:27:45.247Z</lastmod><changefreq>daily</changefreq><priority>0.7</priority></url></urlset>